ENXTPA:MLHK
ENXTPA:MLHKAerospace & Defense

How Investors Are Reacting To H&K (ENXTPA:MLHK) After the U.S. H-1B Visa Fee Challenge

In September 2025, the U.S. Chamber of Commerce filed a lawsuit against the Trump administration, challenging a presidential proclamation that imposes a $100,000 supplemental fee on new H-1B visa petitions submitted from abroad. This legal move underscores the critical influence of immigration policy on companies that depend on access to international skilled workers. We'll explore how the legal uncertainty around the H-1B visa fee could shape H&K's investment narrative and future hiring...
ENXTPA:VLTSA
ENXTPA:VLTSARenewable Energy

Should Voltalia's New IFC Partnership and Plant Launches Prompt a Rethink by ENXTPA:VLTSA Investors?

Voltalia recently announced a collaboration with IFC, a member of the World Bank Group, to develop renewable energy solutions for mining operations across Africa, alongside the commissioning of a major 10.5-megawatt biomass plant in French Guiana and the operational launch of the 45-megawatt Clifton Solar power plant in the UK. These developments highlight Voltalia's increasing capacity to deliver turnkey clean energy projects globally, positioning the company as a growing force in helping...
ENXTPA:SCR
ENXTPA:SCRInsurance

SCOR (ENXTPA:SCR): Assessing Valuation After a 57% Total Return Year

SCOR (ENXTPA:SCR) has been on investors’ radar lately, given its performance over the past year. The stock has delivered a strong 57% total return, easily outpacing many industry peers and catching the attention of market watchers. See our latest analysis for SCOR. SCOR's momentum over the past year has been impressive, with its share price climbing nearly 23% year-to-date and a total shareholder return of almost 57% over twelve months. Short-term volatility, such as this week's pullback, has...
ENXTPA:ADP
ENXTPA:ADPInfrastructure

Aeroports de Paris (ENXTPA:ADP) Is Up 7.2% After Morgan Stanley Upgrade on Regulatory Reassessment Has the Bull Case Changed?

In recent days, Morgan Stanley upgraded Aeroports de Paris from Equalweight to Overweight, highlighting that regulatory risks linked to the upcoming 2025 multi-year regulatory period may have been exaggerated and emphasizing the company’s actions, alongside regulator ART, to reduce related uncertainties. This upgrade draws attention to strong passenger traffic projections for Winter 2025/26 and the significant retail opportunity expected in the latter half of 2026, marking a positive shift...
ENXTPA:MERY
ENXTPA:MERYRetail REITs

Mercialys (ENXTPA:MERY): Assessing Valuation Following Upgraded 2025 Earnings Guidance and Executive Leadership Update

Mercialys (ENXTPA:MERY) caught investor attention after raising its full-year earnings per share guidance for 2025. This signals stronger-than-expected financial performance. This update came as the company shared news of a leadership transition. See our latest analysis for Mercialys. While Mercialys' upgraded earnings outlook and leadership transition made headlines, the 2025 share price has been steady but not without short-term turbulence, with a recent dip of just under 1% this week...
ENXTPA:MERY
ENXTPA:MERYRetail REITs

Should Mercialys’s (ENXTPA:MERY) CEO Transition and Upgraded Earnings Outlook Prompt Investor Reassessment?

Mercialys announced that Deputy CEO Elizabeth Blaise will step down from her position effective December 31, 2025, following over a decade with the company, and outlined the accompanying compensation terms and a 12-month non-compete agreement pending shareholder approval. Alongside this leadership transition, the Board reaffirmed raised full-year earnings guidance, signaling confidence in the existing management team and a strong operational outlook. We'll explore how Mercialys's upgraded...
ENXTPA:ATE
ENXTPA:ATEIT

Leadership Overhaul Might Change The Case For Investing In Alten (ENXTPA:ATE)

Earlier in October 2025, Alten's Board of Directors approved the separation of the Chairman and CEO roles, appointing Cyril Malargé as Chief Executive Officer and welcoming Danièle Guyot-Caparros as an independent director and Audit Committee chair following board resignations. This leadership transition introduces new executive and board expertise, potentially affecting Alten's governance priorities and approach to business transformation moving forward. We'll examine how the arrival of...
ENXTPA:EL
ENXTPA:ELMedical Equipment

EssilorLuxottica (ENXTPA:EL) Valuation in Focus Following Record Revenue From AI Glasses Launch

EssilorLuxottica (ENXTPA:EL) just reported its strongest quarterly revenue ever, pushing its shares to a record high. The main driver was surging demand for its AI-powered smart glasses, particularly those created with Meta. See our latest analysis for EssilorLuxottica Société anonyme. EssilorLuxottica’s shares have jumped over 13% in the past week alone, reaching an all-time high as enthusiasm builds around its recent sales momentum and blockbuster AI-glasses launch. The company’s one-year...
ENXTPA:OVH
ENXTPA:OVHIT

A Look at OVHcloud’s (ENXTPA:OVH) Valuation Following Its Bitdefender Cybersecurity Partnership and Sector Tailwinds

OVH Groupe (ENXTPA:OVH) just announced a strategic partnership with Bitdefender to deliver sovereign cybersecurity services in France, an important move that reinforces OVHcloud’s credentials with EU data compliance. This collaboration spotlights OVHcloud’s certified SecNumCloud offering amid growing interest in secure, AI-ready cloud infrastructure. See our latest analysis for OVH Groupe. OVH Groupe’s new cybersecurity partnership comes on the heels of industry-wide momentum at OpenInfra...
ENXTPA:ALO
ENXTPA:ALOMachinery

A Look at Alstom (ENXTPA:ALO) Valuation Following CEO Transition Announcement

Alstom (ENXTPA:ALO) has named Martin Sion as its next CEO, with the transition scheduled for April 2026. The decision follows a period of careful succession planning and signals stability at the company’s top levels. See our latest analysis for Alstom. Alstom’s share price has been relatively steady this year, with a recent uptick as attention turned to its leadership changes and strategic direction. The 1-year total shareholder return of nearly 7% hints at improving investor sentiment. In...
ENXTPA:VIRP
ENXTPA:VIRPPharmaceuticals

A Look at Virbac (ENXTPA:VIRP) Valuation Following Upgraded 2025 Guidance and Strong Q3 Results

Virbac (ENXTPA:VIRP) just raised its 2025 revenue guidance following a solid third quarter, now expecting annual growth between 5.5% and 7.5%. This updated outlook is attracting the attention of investors. See our latest analysis for Virbac. Following this upbeat guidance, Virbac’s share price jumped more than 7% in a single day, reversing recent declines and signaling renewed optimism around the company’s growth outlook. While the stock is still down slightly on a one-year total shareholder...
ENXTPA:CS
ENXTPA:CSInsurance

AXA’s New Bolttech Partnership Might Change The Case For Investing In AXA (ENXTPA:CS)

AXA Partners recently announced a collaboration with insurtech firm Bolttech to expand embedded insurance solutions throughout Europe, focusing on improved distribution and integration with digital platforms. This alliance marks a meaningful step in AXA's ongoing efforts to broaden its reach in the fast-evolving embedded insurance market and deepen connections with digital-first customers. We'll assess how the embedded insurance partnership could impact AXA's digital expansion and...
ENXTPA:RBO
ENXTPA:RBOConsumer Durables

European Growth Stocks Insiders Are Betting On

As the European market navigates through a mixed economic landscape, with the pan-European STOXX Europe 600 Index seeing modest gains amid dovish signals from U.S. Fed Chair Jerome Powell and easing trade tensions, investors are keenly observing sectors poised for growth. In this context, stocks with high insider ownership often attract attention as they suggest confidence from those closest to the company’s operations; this can be particularly compelling in uncertain times where insider bets...
ENXTPA:MAU
ENXTPA:MAUOil and Gas

Maurel & Prom (ENXTPA:MAU): Assessing Valuation After Q3 Sales and Production Growth Update

Etablissements Maurel & Prom (ENXTPA:MAU) has released its sales and production numbers for the third quarter and the first nine months of 2025. Sales reached $200 million last quarter, while production increased compared to the same period last year. See our latest analysis for Etablissements Maurel & Prom. Despite the boost in production and fresh sales figures, Etablissements Maurel & Prom’s share price fell nearly 24% year-to-date, reflecting cautious sentiment. At the same time, the...
ENXTPA:SW
ENXTPA:SWHospitality

A Look at Sodexo (ENXTPA:SW) Valuation Following Thierry Delaporte’s Appointment as CEO

Sodexo (ENXTPA:SW) has unveiled a major leadership transition, naming Thierry Delaporte as its next Group Chief Executive Officer. Delaporte's background in global transformation could bring new perspectives to Sodexo's strategy and operational direction. See our latest analysis for Sodexo. Sodexo’s share price has rebounded over the past month, gaining 4.2%, and climbed even further this week with a 5.1% return as investors reacted to the leadership shakeup. While this momentum is...
ENXTPA:RMS
ENXTPA:RMSLuxury

Hermès (ENXTPA:RMS) Valuation in Focus After Creative Leadership Shift Announced

Hermès International Société en commandite par actions (ENXTPA:RMS) will soon bid farewell to Veronique Nichanian, its artistic director of menswear for almost forty years. The announcement sets the stage for shifts in the brand’s creative direction. See our latest analysis for Hermès International Société en commandite par actions. Hermès International’s share price recently bounced back, climbing 7.7% over the past week alone, although it remains down slightly for the year so far. Despite...
ENXTPA:PLNW
ENXTPA:PLNWSoftware

Planisware (ENXTPA:PLNW): Exploring Current Valuation Following Recent Share Price Momentum

Planisware SAS (ENXTPA:PLNW) shares have seen a range of moves over the past month, providing investors with an interesting snapshot of how the market currently values enterprise project management software companies in Europe. The stock’s performance has prompted several questions about future growth. See our latest analysis for Planisware SAS. Planisware SAS has bounced around in recent months, with a strong 1-month share price return of nearly 9% suggesting renewed interest after a tough...
ENXTPA:EN
ENXTPA:ENConstruction

Is Bouygues Still Attractive After 43% Price Surge and Strong Construction Pipeline in 2025?

If you are eyeing Bouygues and wondering whether now is the time to buy, sell, or just hold, you are not alone. With every upswing and dip, investors want to know what is really driving this stock, and is it still a bargain? Over the past year, Bouygues has delivered an impressive performance. The stock is up 8.4% in just the past week, 11.2% over the last month, and an astonishing 43.1% for the year to date. Looking back even further, returns have compounded to 77.7% over three years and...
ENXTPA:DG
ENXTPA:DGConstruction

Vinci (ENXTPA:DG): Assessing Valuation After Strong Q3 Airport Traffic Growth and Cambodia Expansion

Vinci (ENXTPA:DG) just released its third quarter traffic results, showing VINCI Airports handled 94 million passengers, which is a 4% climb from last year. Expansion into Cambodia’s Techo International Airport also contributed to this growth. See our latest analysis for Vinci. Vinci’s recent traffic gains come as the share price has climbed 21.8% year-to-date to €121.4, with momentum picking up after new airport projects and increased passenger volumes. Over the longer term, Vinci’s 3-year...
ENXTPA:CA
ENXTPA:CAConsumer Retailing

Is Carrefour’s Share Price Rally in 2025 Justified After Its Recent Earnings Recovery?

If you own Carrefour stock or you’re thinking about jumping in, you might be wondering what’s next for this retail heavyweight. Over the past month, Carrefour’s share price has climbed a sturdy 10.1%, putting a spring in the step of anyone watching for signs of growth. Even over the past week, the stock notched up another 3.3%. Despite these recent gains, the stock is still down 2.3% so far this year and trails by 4.0% over the last twelve months. Looking further back, there is a respectable...
ENXTPA:DIM
ENXTPA:DIMLife Sciences

Sartorius Stedim Biotech (ENXTPA:DIM) Is Up 8.0% After Raising Guidance on Stronger Earnings and New Cell Therapy Partnership – What's Changed

Sartorius Stedim Biotech reported third quarter and nine-month results for 2025, showing sales of €705.7 million and €2.20 billion, with net income rising to €64.2 million and €218.3 million, respectively, both up from the previous year. The company raised its full-year guidance, expanded its product range, and began a collaboration with Nanotein Technologies, pointing to focused innovation in cell therapy manufacturing. We'll examine how stronger earnings and revised guidance could shape...
ENXTPA:MEDCL
ENXTPA:MEDCLPharmaceuticals

A Closer Look at MedinCell (ENXTPA:MEDCL) Valuation Following FDA Approval for UZEDY in Bipolar I Disorder

MedinCell (ENXTPA:MEDCL) shares drew attention after the U.S. FDA cleared UZEDY, its long-acting risperidone injection, for use as a monthly treatment in adults with bipolar I disorder. This marks an added approval beyond schizophrenia. See our latest analysis for MedinCell. MedinCell’s share price has surged recently, booking a 64.2% gain over the past month and notching a remarkable 111.9% share price return in the last 90 days. Momentum clearly accelerated since the FDA expanded UZEDY’s...